Zoetis | ZTS - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
AbbVie USD 5.57B 2.9B 2026-03
Align Technology USD 148.89M 27.71M 2026-03
Bayer EUR -3.37B 2.21B 2025-12
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Coherus Biosciences USD -46.35M 90.86M 2025-12
Dentsply International USD -42M 105M 2026-03
Eli Lilly USD 8.27B 1.03B 2025-12
Henry Schein USD 150M 17M 2026-03
Idexx Laboratories USD 355.44M 48.46M 2026-03
Illumina USD 157M 220M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
J&J USD 7.82B 2.86B 2026-03
Laboratory Of America USD 8.73B 8.54B 2026-03
Merck USD 3.42B 3.32B 2025-12
Neogen USD 28M 15.81M 2025-09
Pacira USD 571K 8.95M 2025-12
Perrigo USD -1.33B 1.35B 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Phibro Animal Health USD 38.62M 1.26M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Sanofi EUR -1.16B 5.5B 2025-12
Sanofi EUR 2B 3.16B 2026-03
Zoetis USD 761M 126M 2025-12